59% Agree: Other Countries Are Free-Riding On U.S. Research

Publication Date: 05/14/2025 6:11 PM CST

59% Agree: Other Countries Are Free-Riding On U.S. Research

Publication: 05/14/2025 6:11 PM CST

Member Content

The content you are trying to access is currently only available to Gold Circle Members. If you are a member, please log in to view.

To learn more about becoming a Gold Circle Member, please refer to our membership page.

Full Toplines: RESTRICTED

Full Crosstabs URL: RESTRICTED

Toplines are free for use after embargo, if any. Crosstabs are confidential and not for public release. However, you may cite specific demographic data from these reports.
For any data released, please cite Napolitan News Service.

Public Content

When it comes to pharmaceutical drug prices, 59% of voters agree with President Trump's claims that other countries are unfairly free-riding on U.S. research in a way that harms U.S. consumers.

A Napolitan News Survey found that this includes 83% of Republicans and 37% of Democrats.

For voters, this issue is not as important as tariffs. Twenty percent (20%) say they are very closely following news about President Trump's plan to reduce pharmaceutical drug costs. That's significantly lower than the 30% very closely following stories about tariffs in a recent survey.

The most recent data cited is from a Napolitan News Service survey of 1,000 Registered Voters conducted online by Scott Rasmussen May 12-13, 2025. Field work for the survey was conducted by RMG Research, Inc. and has a margin of error of +/- 3.1.